Where can I buy Wegovy?
Wegovy, also known as semaglutide, is a ground-breaking weight loss medication developed by Novo Nordisk, the Danish pharmaceutical manufacturer which can lead to weight loss of 15-20% in just over a year.
Wegovy is now available with CheqUp
Wegovy is a once-weekly injection which works by mimicking the action of GLP-1, a hormone that regulates appetite and glucose metabolism. It is approved by the UK medicines regulator (the MHRA) for weight management in people with a BMI equal to or greater than 30. It works by suppressing appetite which leads people to eat less and lose weight. In clinical trials, Wegovy showed weight loss of 15-20% in many people.
Wegovy was launched in the UK in September 2023 but chronic shortages have made it very hard for people to buy.
However, CheqUp is delighted to be able to stock the first three doses of Wegovy (0.25mg, 0.5mg and 1.0mg) which is enough for at least the first three months. As soon as more doses become available we'll be offering them to our customers. You can buy Wegovy today and start your weight loss journey by clicking on the button below.
What do I need to buy Wegovy?
Wegovy is a prescription drug which must be prescribed by a fully-qualified doctor and administered as part of a weight management programme. We ask you to complete an online medical questionnaire and to help us to verify your identification - so we know we are only prescribing Wegoy to people for whom it is safe.
All requests to buy Wegovy are fully reviewed by a CheqUp doctor who retains medical oversight throughout the treatment.
We provide access to dietitians, physical activity advisors, psychologists and health coaches to help you reach your weight loss goals.
How does Wegovy work?
Wegovy is a GLP-1 medication that mimics our body’s natural gut hormones by telling our brains that we are full and do not need to eat any more. They will also slow the movement of food from the stomach into the small intestine. As a result, you may feel full faster and longer, so you eat less.
Along with helping to control blood sugar and boost weight loss, GLP-1s and SGLT-2 inhibitors seem to have other major benefits. Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease. People taking these drugs have seen their blood pressure and cholesterol levels improve.
Published: 31 Oct 2023